Internal Medicine On Demand: Cardiometabolic Update
|
$399.20
Use promo code (Limited Time Offer)
15 CREDITS
  Hurry! Offer expires January 1, 2023 at 11:59 pm ET!
|
|
A collection of recorded video lectures from recent conferencesCourse Content
| Session | Title | Faculty |
| Session 1 (36 minutes) | Resistant and Difficult-to-Treat Hypertension: What's Best, What's Next | K. Ferdinand, MD |
| Session 2 (41 minutes) | Self Monitoring of BP: Why it is So Important | D. Shimbo, MD |
| Session 3 (51 minutes) | Diabetes and Hypertension in the African American Patient: Present and Emerging Approaches | K. Ferdinand, MD |
| Session 4 (43 minutes) | A Clinical Update on White Coat and Masked Hypertension | D. Shimbo, MD |
| Session 5 (48 minutes) | 10 Practical Messages: What Can We Learn From the 2019 ACC/AHA Cardiovascular Disease Prevention Guidelines | S. Virani, MD |
| Session 6 (42 minutes) | New Insights on Triglyceride Reduction in CV Risk Reduction | S. Virani, MD |
| Session 7 (55 minutes) | Putting It All Together: Case Studies to Guide Management of Heart Failure | A. Morris, MD |
| Session 8 (77 minutes) | Type 2 Diabetes: New Guidelines and Controversies | J. Buse, MD |
| Session 9 (43 minutes) | GLP-1 Receptor Agonists and SGLT2 Inhibitors: Where Do They Fit and How to Implement Them in Primary Care Practice | J. Buse, MD |
| Session 10 (68 minutes) | Diabetes Cases (Panel) | J. Buse, MD & H. Gerstein, MD |
| Session 11 (59 minutes) | Cases on Lipids and Diabetes (Panel) | S. Virani, MD & K. Pantalone, DO |
| Session 12 (61 minutes) | Challenging Cases in Hypertension, Heart Failure, and the High Risk Cardio-Metabolic Patient (Panel) | K. Ferdinand, MD & J. Basile, MD |
| Session 13 (61 minutes) | The Interdisciplinary Treatment of Obesity: Focus on Anti-obesity Medications | B. Burguera, MD |
| Session 14 (62 minutes) | The Role of Lifestyle Interventions in the Treatment of Obesity | C. Still, DO |
| Session 15 (58 minutes) | Bariatric Surgery: In Whom, Which One, and How to Monitor Afterwards | C. Still, DO |
| Session 16 (101 minutes) | Obesity Case Studies (Panel) | B. Burguera, MD & C. Still, DO |
Program Overview
Cardiometabolic disorders are a cluster of health conditions associated with cardiovascular disease and type 2 diabetes. It is estimated that over 1/3 of American’s suffer from a cardiometabolic disorder. The associated morbidity and mortality deserve increased clinical attention as we address risk factors predisposing individuals to these disorders. Internal Medicine On Demand: Cardiometabolic Update will address issues confronting the clinician who treats challenging patients with diabetes, hypertension, and dyslipidemia. The course will help identify these conditions and their related complications to enable clinicians to appropriately intervene with evidence-based treatments and risk-factor control while improving patient education.
Learning Objectives:
As a result of this educational activity, participants should be better able to:
- Diagnose and identify cardiometabolic risk factors, including diabetes, dyslipidemia, hypertension, and obesity.
- Integrate evidence-based strategies and recent guidelines for the screening, prevention, and treatment of cardiometabolic risk factors and their comorbidities in clinical practice.
- Incorporate appropriate interventions, including lifestyle modifications, nutrition counseling, and drug and surgical therapies, based on a specific patient’s risk profile.
Post-Test and Evaluation:
After completing the CME activity, you must successfully complete a post-test and fill out a program evaluation form. You will then be able to view and print your CME certificate. Login into CME365 to view your transcript and reprint your certificate at any time.
Faculty
Jan N. Basile, MD, FACP, FASH, FAHA
Professor of Medicine
Seinsheimer Cardiovascular Health Program
Medical University of South Carolina
Ralph H. Johnson VA Medical Center
Charleston, SC
Bartolome Burguera MD, PhD
Professor of Medicine
Cleveland Clinic Lerner College of Medicine
Chairman of Endocrinology and Metabolism Institute
Cleveland, OH
John B. Buse, MD, PhD
Verne S. Caviness Distinguished Professor
Director, Diabetes Center
Chief, Division of Endocrinology
Executive Associate Dean, Clinical Research
University of North Carolina School of Medicine
Chapel Hill, NC
Keith C. Ferdinand, MD, FACC, FAHA, FASH, FNLA
Gerald S. Endowed Chair in Preventive Cardiology
Professor of Medicine
Tulane University School of Medicine
Tulane Heart and Vascular Institute
New Orleans, LA
Hertzel C. Gerstein MD, MSc, FRCPC
Professor at McMaster University and Hamilton Health Sciences
Population Health Research Institute Chair in Diabetes
Director of the Division of Endocrinology & Metabolism
Director of the Diabetes Care and Research Program
Deputy Director of the Population Health Research Institute
Hamilton, Ontario, Canada
Alanna A. Morris, MD, MSc, FHFSA, FACC
Assistant Professor of Medicine
Advanced Heart Failure and Transplant/LVAD
Emory University School of Medicine
Emory Clinical Cardiovascular Research Institute
Atlanta, GA
Kevin M. Pantalone, DO, ECNU, FACE
Staff Endocrinologist
Director of Clinical Research, Department of Endocrinology
Cleveland Clinic
Cleveland, OH
Daichi Shimbo, MD
Associate Professor of Medicine
Ewig Clinical Scholar, Department of Medicine
Columbia University
New York City, NY
Christopher D. Still, DO, FACN, FACP, FTOS
Director, Geisinger Obesity Institute
Medical Director, Center for Nutrition and Weight Management
Medical Director, Employee Wellness
Associate, Department of Gastroenterology and Nutrition
Geisinger Health Care System
Danville, PA
Salim S. Virani, MD, PhD, FACC, FAHA
Professor, Section of Cardiovascular Research
Director, Cardiology Fellowship Training Program
Baylor College of Medicine
Staff Cardiologist, Michael E. DeBakey VA Medical Center
Houston, TX
Accreditation
AMA PRA Category 1 Credits™: Continuing Education Company, Inc. is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Continuing Education Company designates this enduring material for a maximum of 15 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
ABIM MOC: Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 15 Medical Knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. Please allow 6-8 weeks for your MOC points to appear on your ABIM records.
AAPA: AAPA accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society. Physician assistants may receive a maximum of 15 hours of Category 1 credit for completing this activity.
AANPCB: The American Academy of Nurse Practitioners Certification Board (AANPCB) accepts AMA PRA Category 1 Credit™ from organizations accredited by the ACCME. Nurse Practitioners may receive a maximum of 15 hours of participation, 9 of which can be used towards Pharmacology, for completing this activity.
Release Date: 4/10/2020
Expiration Date: 4/10/2023 (Date after which this enduring material is no longer certified for credit.)
Medium: Internet/Enduring Material, Video/Audio
Faculty/Planning Committee Disclosures
Review and Planning Committee Disclosures:
The following individuals have indicated that he/she (nor spouse/partner) has no relevant financial relationships with a commercial interest that may impact upon this CME activity:
- Raymond E. Major - Reviewer
- Walter Ejnes, CHCP - Reviewer & Planning Committee (Continuing Education Company)
- Beth Townsend - Reviewer (Continuing Education Company)
- Su Barnwell - Planning Committee (Continuing Education Company)
Faculty Disclosures:
The following individuals have indicated that he/she (nor spouse/partner) have no relevant financial relationships with a commercial interest that may impact upon this CME activity:
| Faculty | Disclosure |
| Jan N. Basile, MD | Consultant: Medtronic Adjudication Committee and Up-to-Date (Hypertension Section) Consultant, Research Grant: ReCor (RADIANCE) Research Grant: Eli Lilly and NHLBI (SPRINT) |
| Bartolome Burguera MD, PhD | Consulting Fees, Research Grant: Novo Nordisk |
| John B. Buse, MD | Consulting Fees to UNC: Adocia, AstraZeneca, Dance Biopharm, Eli Lilly, MannKind, NovaTarg, Senseonics, and Zafgen Consulting Fees to UNC, Research Grant: Novo Nordisk and vTv Therapeutics Consultant: Cirius Therapeutics, Inc., CSL Behring, and Neurimmune AG Research Grant: Sanofi Stockholder: Mellitus Health, PhaseBio, and Stability Health |
| Keith C. Ferdinand, MD | Consultant: Amgen, Boehringer-Ingelheim, Novartis, Quantum, Genomics, Sanofi |
| Hertzel C. Gerstein MD, | Advisory Board: Abbott Diagnostic, Boehringer-Ingelheim, and Janssen Advisory Board, Consultant, Research Grant: AstraZeneca, Eli Lilly, Merck, Novo Nordisk, and Sanofi Consultant: Cirius and KOWA |
| Alanna Morris, MD | Nothing to Disclose |
| Kevin M. Pantalone, DO | Advisory Board, Consultant, Research Grant, Speakers Bureau: Merck and Novo Nordisk Consultant: Eli Lilly and Sanofi Speakers Bureau: AstraZeneca |
| Daichi Shimbo, MD | Nothing to Disclose |
| Christopher Still, DO | Advisory Board: KVK Tech Consultant, Research Grant: Ethicon-Endosurgery Consultant, Speakers Bureau: Novo Nordisk |
| Salim S. Virani, MD, PhD | Nothing to Disclose |
Unlabeled Use Declaration:
During their presentation, faculty may discuss unlabeled or investigational use which is not approved for a commercial product. Faculty members are required to disclose this information to the audience when referring to an unlabeled or investigational use.
Statement of Disclosure and Independence:
It is the policy of Continuing Education Company (CEC) to ensure all of its accredited educational activities are designed, implemented, and evaluated in accordance with the Accreditation Council for Continuing Medical Education’s (ACCME) Criteria and Policies. In accordance with ACCME requirements, CEC has Relevant Financial Relationship Disclosure Policies that are designed to ensure that accredited educational activities are fair, balanced, independent, evidence based, and based on scientific rigor.
All individuals who are in position to influence and/or control content of a CEC accredited Continuing Medical Education (CME) activity must disclose any relevant financial interest or other relationships they have with an ineligible company, which is any entity whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. (Relevant financial interest or other relationship includes such things as grants or research support, employee, consultant, major stockholder, member of speakers’ bureau, etc.) The intent of this disclosure is to provide activity participants with information to determine whether the speaker’s interests or relationships may influence the presentation with regard to exposition or conclusions. All relevant financial relationships have been identified, mitigated, and are listed above.
The opinions, ideas, recommendations, and perspectives expressed in the syllabus and accompanying presentations at this activity are those of the program authors and presenting faculty only and do not necessarily reflect the opinions, ideas, recommendations or perspectives of their affiliated institutions, Continuing Education Company, advisory boards or consultants.
Computer Requirements
Flash Player 10 or later, and one of the following browsers:
- Windows: Internet Explorer 6 and later, Microsoft Edge (latest version), Firefox 1.x and later, Google Chrome (latest version), Opera 9.5 and later
- Mac: Safari 3 and later, Firefox 1.x and later, Google Chrome (latest version)
- Linux: Firefox 1.x and later
HTML5 via one of the following browsers:
- Windows: Google Chrome (latest version)
- Mac: Safari 6.0.5 or later, Google Chrome (latest version)
- Mobile: Safari in Apple iOS 6 or later
30 Day Money Back Guarantee
CEC stands behind our product. If you are not satisfied with your online course for any reason, send a written cancellation request and reason to registration@cmemeeting.org within 30 days of the purchase date for a full refund. (Cancellations on CME365™ Collection Series will incur a 5% processing fee.) Please note you may watch any of the content but once you claim credit for any online course, no refund can be granted.